Patents by Inventor Daniel Pagé

Daniel Pagé has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
    Patent number: 8633235
    Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: January 21, 2014
    Assignee: Neomed Institute
    Inventors: Ziping Liu, Daniel Pagé, Christopher Walpole, Hua Yang
  • Cannabinoid Receptor Ligands
    Publication number: 20110160180
    Abstract: Compounds of Formulae (I), or pharmaceutically acceptable salts thereof: wherein R1, R2 and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: August 15, 2008
    Publication date: June 30, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Sara Beha, William Brown, Shawn Johnstone, Ziping Liu, Daniel Pagé, Miroslaw Tomaszewski, Zhong-yong Wei, Shi Yi Yue
  • Compounds, compositions containing them, preparation thereof and uses thereof I
    Patent number: 7550495
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, R5, and G are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: May 22, 2006
    Date of Patent: June 23, 2009
    Assignee: AstraZeneca AB
    Inventors: Daniel Pagé, Ziping Liu, Maxime Tremblay, Christopher Walpole, Hua Yang
  • Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
    Patent number: 7517898
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: April 14, 2009
    Assignee: AstraZeneca AB
    Inventors: Ziping Liu, Daniel Pagé, Christopher Walpole, Hua Yang
  • Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
    Patent number: 7501447
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: March 10, 2009
    Assignee: AstraZeneca AB
    Inventors: Ziping Liu, Daniel Pagé, Christopher Walpole, Hua Yang
  • Compounds
    Patent number: 7407968
    Abstract: Compounds of formula (I) wherein RF1, RF2, Z, R1, R2, Ar, X and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds were prepared. These compounds are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: August 5, 2008
    Assignee: AstraZeneca AB
    Inventors: Daniel Pagé, Christopher Walpole, Hua Yang
  • 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain of gastrointestinal disorders
    Patent number: 7253173
    Abstract: Compounds of general formula (I) wherein R1, R2 and R3 are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: August 7, 2007
    Assignee: AstraZeneca AB
    Inventors: William Brown, Andrew Griffin, Paul Jones, Daniel Pagé, Niklas Plobeck, Christopher Walpole
  • Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
    Patent number: 7244850
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: Formula (I) wherein R1, R2, RF1, RF2 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: July 17, 2007
    Assignee: AstraZeneca AB
    Inventors: Daniel Pagé, Christopher Walpole, Hua Yang
  • Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
    Publication number: 20060205802
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: June 9, 2004
    Publication date: September 14, 2006
    Applicant: AstraZeneca AB
    Inventors: Zipingé Liu, Daniel Pagé, Christopher Walpole, Hua Yang